GMP pharma cannabinoid APIs, providing breakthroughs in formulations and clinical trials .
99% pure cannabinoids production including THC, CBD, CBN, CBG and CBC, supplying all commercial, clinical, and research platforms entities.
200 Tons annual production and growing
1,000,000 Square Feet of GACP Cultivation Facility
65,000 Square Feet of GMP Production Plant and Labs
State-of-the-Art, 50 Kgs/Hr Extraction Capabilities
Highly competitive production capabilities and optimal climate conditions
Innovations to Markets